Clinical and MRI remission in patients with nonradiographic axial spondyloarthritis who received long-term open-label adalimumab treatment: 3-year results of the ABILITY-1 trial

Author(s):
Heijde, D. van der; Sieper, J.; Maksymowych, W.P.; Lambert, R.G.; Chen, S.; Hojnik, M.; Anderson, J.K.; Pangan, A.L.
Published
2018
Publication type
Article / Letter to editor
Anti-TNFAxial spondyloarthritisAdalimumab
Date issued
2018-03-27
Language
English
Is part of
Arthritis Research and Therapy
hdl
1887/76470
doi
10.1186/s13075-018-1556-5